The 22nd PRIME Awards have attracted entries from more organisations than ever before making this one of the strongest and most competitive fields in the event's history. See which pharmas have topped the shortlist
General Manager announces a “fresh start” for the pharma in a slick new office space with the latest technology and design to enable flexible-based working plus connection with patients and partners
There can be clear disagreements over the price which should be paid for a drug, but some features of the reimbursement system mean neither side really knows what the other expects
Six pharmas have expanded their drugs on the PBS this month - including the first biologic added to the scheme for adults with uncontrolled COPD - with two companies scoring a double win
CSL and eight other pharmas have signed a Most Favoured Nation deal with the US, with the Aussie giant saying it does not anticipate any 'material impact' during fiscal year 2027
A survey of US oncologists has revealed what separates highly effective MSL teams from average ones and without prompting, doctors named the companies that stand out
New commercial collaboration bringing together 'complementary strengths' of two pharmas is a stepping-stone to further collaboration across a broad pipeline
Boss warns there is currently no mechanism to disclose a drug’s commercial history citing the example of a treatment originally developed by Big Tobacco
Six Australian companies addressing significant local and global unmet health needs in infectious diseases are getting support to break into commercial success
PBAC will consider eight submissions with three companies laying the groundwork to secure a broad PBS listing recommendation for their immunotherapies
It's been quite the week for this company which announced a new General Manager on Friday and from tomorrow, two of its biggest drugs will be expanded
First-of-its-kind treatment in an area of unmet need scores a Spring PBS listing with the company's GM underlining the importance of innovative medicines for economic growth
After a gruelling decade-long battle, a milestone PBS listing will see this oncology blockbuster made available to thousands of Australians living with certain advanced and metastatic cancers, including rare cancers
The Leukaemia Foundation has launched a campaign to improve financial assistance to people diagnosed with blood cancer, so people don't need to forgo treatment due to lack of funds
Australia's regulator has narrowed the patient population eligible for a breast cancer drug, after initially granting approval for a broader population than other major jurisdictions
Visting Australia this week to join a discussion about the need for policy and access to keep pace with innovation and scientific ambition
Almost six months after the departure of its General Manager, this company has recruited the leader of a rival pharma as its next Aussie boss
The TGA has approved a new single-pill triple therapy for hypertension as Johnson & Johnson and Dr Falk Pharma expand their franchises
At a gala ceremony in Melbourne last night, the Patients Choice Awards named those making a meaningful difference to the lives of patients
Twelve health sector organisations, including three pharmas, have made the exclusive Best Workplaces in Australia 2026 list
Sandoz ANZ General Manager, Clint Holland, has pulled back the curtain on what makes the biosimilar & generics giant one of Australia’s Best Workplaces
While debate over public funding of weight loss drugs continues, Sigma has reported "above the norm" sales growth driven by GLP-1s
